Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/41984
Title: | The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid | Authors: | Van Slambrouck, Jan Schoenaers, Charlotte Laenen , Lies Jin, Xin Beuselinck, Kurt Verdonck, Ann Wauters, Joost MOLENBERGHS, Geert Vanaudenaerde, Bart M. VOS, Robin Mombaerts, Peter Lagrou, Katrien Ceulemans, Laurens J. |
Issue Date: | 2024 | Publisher: | ELSEVIER | Source: | JOURNAL OF VIROLOGICAL METHODS, 323 (Art N° 114848) | Abstract: | Background: Transmission of SARS-CoV-2 from donor to recipient is a clinically relevant risk for developing severe COVID-19 after lung transplantation (LTx). This risk of iatrogenic transmission can be reduced by timely detection of viral RNA or antigen in samples of bronchoalveolar lavage (BAL) fluid obtained at the time of lung procurement. We aimed to retrospectively evaluate the detection of SARS-CoV-2 RNA or antigen in BAL fluid samples using three point-of-care tests (POCTs).Methods: BAL fluid samples came from patients hospitalized in an intensive care unit during the COVID-19 pandemic. These pandemic samples were scored as positive or negative for SARS-CoV-2 by a RT-qPCR comparator assay for orf1ab. Three commercially available POCTs were then evaluated: cobas SARS-CoV-2 & Influenza A/B assay with the cobas Liat RT-qPCR system (Roche Diagnostics), ID NOW COVID-19 and COVID-19 2.0 (Abbott), and SARS-CoV-2 Rapid Antigen Test (RAT) (Roche Diagnostics). Samples from the pre-pandemic era served as negative controls.Results: We analyzed a total of 98 BAL fluid samples, each from a different patient: 58 positive pandemic samples (orf1ab Ct<38), 20 putatively negative pandemic samples (orf1ab Ct >= 38), and 20 pre-pandemic samples. Uni-variate logistic regression shows that the probability of detection was highest for cobas Liat, followed by ID NOW, and then RAT. Of clinical relevance, cobas Liat detected SARS-CoV-2 RNA in 30 of the 31 positive pandemic samples that were collected within 10 days after RT-qPCR diagnosis of SARS-CoV-2 infection. None of the 20 pre-pandemic samples had a false-positive result for any POCT.Conclusions: POCTs enable the detection of SARS-CoV-2 RNA or antigen in BAL fluid samples and may provide additional information to decide if donor lungs are suitable for transplantation. Detection of respiratory pathogens with POCTs at the time of donor lung procurement is a potential strategy to increase safety in LTx by preventing iatrogenic transmission and severe postoperative infections. | Notes: | Ceulemans, LJ (corresponding author), Univ Hosp Leuven, Dept Thorac Surg, Herestr 49, B-3000 Leuven, Belgium. laurens.ceulemans@uzleuven.be |
Keywords: | Bronchoalveolar lavage;COVID-19;Lung transplantation;Point -of -care test;SARS-CoV-2 | Document URI: | http://hdl.handle.net/1942/41984 | ISSN: | 0166-0934 | e-ISSN: | 1879-0984 | DOI: | 10.1016/j.jviromet.2023.114848 | ISI #: | 001113496700001 | Rights: | 2023 Elsevier B.V. All rights reserved. | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid.pdf Restricted Access | Published version | 2.46 MB | Adobe PDF | View/Open Request a copy |
Manuscript_VIRMET-D-23-00305.pdf | Peer-reviewed author version | 1.12 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.